Presentation is loading. Please wait.

Presentation is loading. Please wait.

Renmin Hospital, Wuhan University Ding Xuhong (丁续红)

Similar presentations


Presentation on theme: "Renmin Hospital, Wuhan University Ding Xuhong (丁续红)"— Presentation transcript:

1

2 Renmin Hospital, Wuhan University Ding Xuhong (丁续红)
Asthma Renmin Hospital, Wuhan University Ding Xuhong (丁续红)

3 DEFINITION A clinical syndrome of unknown etiology characterized by three distinct components (1) Recurrent episodes of airway obstruction that resolve spontaneously or as a result of treatment (clinical manifestation)

4 (2)An exaggerated bronchoconstrictor response to stimuli that have little or no effect in nonasthmatic subjects, a phenomenon known as airway hyperresponsiveness (Pathophysiologically) (3) Inflammation of the airways as defined by a variety of criteria (Pathogenesis)

5 PATHOLOGY Constriction of airway smooth muscle
Airway epithelium thickening Mucus plugging

6 Lung Hyperinflation in Asthma

7 Thick bronchi with Mucous plugs

8 Mucous plug in asthma

9 Asthma - Microscopically
Patchy necrosis of epithelium Sub-mucosal glandular hyperplasia Hypertrophy of bronchial smooth muscle Eosinophils, mast cells, lymphocytes (Th2) infiltration

10

11

12 Asthma Microscopic Pathology
Obstructed Inflammed Bronchi

13 PATHOGENESIS OF ASTHMA

14 Asthma Pathogenetic Types
Extrinsic (Allergic/Immune) Atopic - IgE Occupational - IgG Allergic Bronchopulmonary Aspergillosis - IgE Intrinsic (Non-immune) Aspirin induced Infection induced

15

16 Risk Factors that Lead to Asthma Development
Predisposing Factors Atopy Causal Factors Indoor Allergens Domestic mites Animal Allergens Cockroach Allergens Fungi Outdoor Allergens Pollens Occupational Sensitizers Contributing Factors Respiratory infections Small size at birth Diet Air pollution Outdoor pollutants Indoor pollutants Smoking Passive Smoking Active Smoking

17 Airway Hyperresponsiveness Genetic Inducers Allergens,Chemical sensitisers, Air pollutants, Virus infections INFLAMMATION Airflow Limitation SYMPTOMS Cough Wheeze Dyspnoea Triggers Allergens, Exercise, Cold Air, SO Particulates

18 DIAGNOSIS OF ASTHMA History and patterns of symptoms
Physical examination Measurements of lung function

19 PATIENT HISTORY Has the patient had an attack or recurrent episodes of wheezing? Does the patient have a troublesome cough, worse particularly at night, or on awakening? Does the patient cough after physical activity (e.g playing)? Does the patient have breathing problems during a particular season (or change of season)?

20 Do the patient’s colds ‘go to the chest’ or take more than 10 days to resolve?
Does the patient use any medication (e.g. bronchodilator) when symptoms occur? Is there a response? If the patient answers “YES” to any of the above questions, suspect asthma

21 Physical Examination Wheeze -Usually heard without a Remember -
stethoscope Dyspnoea Rhonchi heard with a stethoscope Use of accessory muscles Remember - Absence of symptoms at the time of examination does not exclude the diagnosis of asthma

22 Blood Finding Blood eosinophilia, elevated serum level of sIgE
Arterial blood gases: PaO2 between 55 and 70mmHg PaCO2 between 25 and 35mmHg

23 Radiographic finding In severe asthma, hyperinflation, pneumomediastinum or pneumothorax may be detected

24 ECG Sinus tachycardia (usually), right axis deviation, right bundle branch block, “P pulmonale”, ST-T wave abnormalities (severe asthma)

25 Diagnostic testing Diagnosis of asthma can be confirmed by demonstrating the presence of reversible and variable airway obstruction using Peak Flow Meter

26 Bronchial challenge test: PC20<8mg/mL
Reversibility test: FEV1 increase more than 12% after inhalation of salbutamol, the absolute value of increase >200ml Variability of PEF diurnally ≥20%

27 Differential diagnosis
Chronic bronchitis Heart failure (“cardiac asthma”) Hypersensitivity pneumonia Lung cancer

28 Goals to Be Achieved in Asthma Control
Achieve and maintain control of symptoms Prevent asthma episodes or attacks Minimal use of reliever medication No emergency visits to doctors or hospitals Maintain normal activity levels, including exercise Maintain pulmonary function as close to normal as possible Minimal (or no) adverse effects from medicine

29 Tool Kit for Achieving Management Goals
Relievers Preventers Peak flow meter Patient education

30 What Are Relievers? (also known as rescue medication)
Bronchodilator (beta2 agonist) Quick relief of symptoms (within 2-3 minutes) Used during acute attacks Action lasts 4-6 hrs Not for regular use

31 Relievers Short acting 2 agonists Salbutamol (万托林) Anti-cholinergics
Ipratropium bromide(爱全乐) Xanthines Theophylline Adrenaline injections

32 What are Preventers? Anti-inflammatory Takes time to act (1-3 hours)
Long-term effect (12-24 hours) Only for regular use (whether well or not well)

33 Prevent future attacks
Long term control of asthma Prevent airway remodeling

34 Preventers Corticosteroids Anti-leukotrienes
Prednisolone, Betamethasone Montelukast, Zafirlukast Beclomethasone, Budesonide Fluticasone Xanthines Theophylline SR Long acting 2 agonists Mast cell stabilisers Bambuterol, Salmeterol Sodium cromoglycate Formoterol COMBINATIONS Salmeterol/Fluticasone Formoterol/Budesonide

35 Patient Education in the Clinic
Explain nature of the disease (i.e. inflammation) Explain action of prescribed drugs Stress need for regular, long-term therapy Allay fears and concerns Peak flow reading Treatment diary / booklet

36 Status Asthmatic FEV1 < 40%pred with treatment, PaCO2 increases, developing major complication such as pneumothorax Close monitoring Frequent treatments with inhaled β2-agonists, intravenous aminophylline, high-dose intravenous steroid Oxygen supplement Antibiotics – if infection exist If indicated, intubation of the trachea and mechanical ventilation

37 The Pregnant Asthmatic
No departure from the ordinary management of asthma No unnecessary medication should be administered Systemic steroid should be used sparingly Tetracycline, atropine, terbutaline(博利康尼?), iodine-containing mucolytics should be avoided

38 Key Messages Asthma is a common disorder
It produces recurrent attacks of cough with or without wheeze Between attacks people with asthma lead normal lives as anyone else In most cases there is some history of allergy in the family

39 Asthma can be effectively controlled, although it cannot be cured
Effective asthma management programs include education, objective measures of lung function, environmental control, and pharmacologic therapy A stepwise approach to pharmacologic therapy is recommended. The aim is to accomplish the goals of therapy with the least possible medication

40 Thank you!


Download ppt "Renmin Hospital, Wuhan University Ding Xuhong (丁续红)"

Similar presentations


Ads by Google